Home
>
National Drug Code (NDC)
>
Lunesta
Lunesta - 60760-191-30 - (ESZOPICLONE)
Drug Information of Lunesta
| Product NDC: | 60760-191 |
| Proprietary Name: | Lunesta |
| Non Proprietary Name: | ESZOPICLONE |
| Active Ingredient(s): | 2 mg/1 & nbsp; ESZOPICLONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lunesta
| Product NDC: | 60760-191 |
| Labeler Name: | St Marys Medical Park Pharmacy |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021476 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050404 |
Package Information of Lunesta
| Package NDC: | 60760-191-30 |
| Package Description: | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (60760-191-30) |
NDC Information of Lunesta
| NDC Code | 60760-191-30 |
| Proprietary Name | Lunesta |
| Package Description | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (60760-191-30) |
| Product NDC | 60760-191 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ESZOPICLONE |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050404 |
| Marketing Category Name | NDA |
| Labeler Name | St Marys Medical Park Pharmacy |
| Substance Name | ESZOPICLONE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
